five

Supplementary Material for: The Efficacy of Antidepressants on Overall Well-Being and Self-Reported Depression Symptom Severity in Youth: A Meta-Analysis

收藏
Mendeley Data2024-06-25 更新2024-06-27 收录
下载链接:
https://karger.figshare.com/articles/dataset/Supplementary_Material_for_The_Efficacy_of_Antidepressants_on_Overall_Well-Being_and_Self-Reported_Depression_Symptom_Severity_in_Youth_A_Meta-Analysis/5125780
下载链接
链接失效反馈
官方服务:
资源简介:
Background: Recent meta-analyses of the efficacy of second-generation antidepressants for youth have concluded that such drugs possess a statistically significant advantage over placebo in terms of clinician-rated depressive symptoms. However, no meta-analysis has included measures of quality of life, global mental health, self-esteem, or autonomy. Further, prior meta-analyses have not included self-reports of depressive symptoms. Methods: Studies were selected through searching Medline, PsycINFO, and the Cochrane Central Register for Controlled Trials databases as well as GlaxoSmithKline's online trial registry. We included self-reports of depressive symptoms and pooled measures of quality of life, global mental health, self-esteem, and autonomous functioning as a proxy for overall well-being. Results: We found a nonsignificant difference between second-generation antidepressants and placebo in terms of self-reported depressive symptoms (k = 6 trials, g = 0.06, p = 0.36). Further, pooled across measures of quality of life, global mental health, self-esteem, and autonomy, antidepressants yielded no significant advantage over placebo (k = 3 trials, g = 0.11, p = 0.13). Discussion: Though limited by a small number of trials, our analyses suggest that antidepressants offer little to no benefit in improving overall well-being among depressed children and adolescents.

研究背景:近期针对青少年第二代抗抑郁药疗效的荟萃分析(meta-analysis)得出结论,这类药物在临床医师评定的抑郁症状方面,较安慰剂具有统计学意义上的显著优势。然而,尚无任何一项荟萃分析纳入生活质量、整体心理健康、自尊或自主性相关的测评指标。此外,既往荟萃分析亦未纳入抑郁症状的自评报告。 研究方法:本研究通过检索Medline、PsycINFO以及Cochrane对照试验中央登记库(Cochrane Central Register for Controlled Trials)数据库,同时检索葛兰素史克(GlaxoSmithKline)在线试验注册库,筛选纳入相关研究。本研究纳入抑郁症状自评报告,并将生活质量、整体心理健康、自尊以及自主功能的合并测评指标作为总体幸福感的替代评价指标。 研究结果:本研究发现,第二代抗抑郁药与安慰剂在自评抑郁症状方面无显著差异(k = 6项试验,g = 0.06,p = 0.36)。进一步针对生活质量、整体心理健康、自尊及自主性相关指标的合并分析显示,抗抑郁药较安慰剂未展现出显著优势(k = 3项试验,g = 0.11,p = 0.13)。 研究讨论:尽管受限于试验数量较少,但本研究的分析结果表明,抗抑郁药在改善抑郁儿童及青少年的总体幸福感方面,仅具备极微甚至不存在有益效果。
创建时间:
2023-06-28
二维码
社区交流群
二维码
科研交流群
商业服务